Positron emission tomography/computed tomography (PET/CT) using Gallium-68-labelled (Ga-68) ligands that target the prostate-specific membrane antigen (PSMA) is a sensitive and specific diagnostic method that is dedicated to poorly differentiated prostate cancer. This evidence concerns the gene FOLH1 and prostate cancer.